SEC Form D · filed March 6, 2018
Sun BioPharma, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Dalvir S. Gill · WACONIA, MNDirectorScott R. Kellen · WACONIA, MNExecD. R. Schemel · WACONIA, MNDirectorJeffrey S. Mathiesen · WACONIA, MNDirectorDavid B. Kaysen · WACONIA, MNExec · DirectorMichael T. Cullen · WACONIA, MNExec · DirectorSuzanne T. Gagnon · WACONIA, MNDirectorPaul W. Schaffer · WACONIA, MNDirectorJ. R. Paulson, Jr · WACONIA, MNDirectorJan E. Frogg · Grand Cayman, Cayman IslandsDirectorCarl Y. Baggett · Dallas, TXDirectorDavid Bree · Grand Cayman, Cayman IslandsDirectorMark E. Stabile · Grand Cayman, Cayman IslandsExec · DirectorJonathan Roney · GEORGE TOWN, Grand Cayman, Cayman IslandsDirectorMichael A. Harmon · Everett, WAExec · DirectorThomas P. Hoban, Jr · Everett, WAExecMatthew Nyren · New York, NYDirectorColin Mackay · GEORGE TOWN, Grand Cayman, Cayman IslandsDirectorShawn A. Hoban · Everett, WADirectorMichael Wasser · Seattle, WADirectorGregory Kris · Chicago, ILDirectorMonroe Capital, Inc · Rochester, NYExec · DirectorBridget Martin · Rochester, NYDirectorPaul Adams · Rochester, NYDirectorJohn W. Rosenthal · Mishawaka, INExecSarah Blankinship · Seattle, WAExec · DirectorLauren Mulholland · Lexington, KYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗